Table 1 provides a summary of in vivo and in vitro models that investigate the effects of sulforaphane on memory impairment and pre-clinical biomarkers associated with AD, such as neuroinflammation, oxidative stress, tau hyperphosphorylation, amyloid-β, and neurodegeneration. Here, MAPT is linked to Alzheimer disease.